1. St. Jude Medical's CEO Discusses Q4 2011 Results - Earnings Call Transcript

    St. Jude Medical's CEO Discusses Q4 2011 Results - Earnings Call Transcript
    A review of our FFR growth driver naturally leads to a discussion of our intravascular imaging business. We entered the $500 million market for intravascular imaging in the third quarter of 2010 with the world's first Optical Coherence Tomography or OCT technology. We consider this to be a next-generation technology which can compete successfully against the state of the art at the time, which was intravascular ultrasound or IVUS technology. Now that we have 6 quarters of experience marketing our OCT technology, our optimism about its growth potential has been validated. We expect to exit 2012 with between a ...
    Read Full Article

    Login to comment.

  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Topics Mentioned